Skip to main content

Table 2 Cognitive test performances

From: The impact of homocysteine, B12, and D vitamins levels on functional neurocognitive performance in HIV-positive subjects

 

Median (IQR)

Normality Range/Cut-off

Pathologic Test, n (%)

MEMORY

  

12 (21.1)*

 Rey BT

39.0 (34.0–44.0)

> 28.53

9 (15.8)

 Rey LT

8.0 (6.0–10.0)

> 4.69

11 (19.3)

ATTENTION AND WORKING MEMORY

  

38 (66.7)*

 Verbal Span forward

5.0 (4.0–6.0)

5.00–9.00

18 (31.6)

 Spatial Span forward

3.0 (3.0–5.0)

5.00–9.00

37 (64.9)

 Double barrage

1.0 (1.0–1.0)

> 0.92

6 (10.5)

EXECUTIVE FUNCTIONS

  

33 (57.9)*

 Stroop E

1.0 (0–2.0)

< 4.24

8 (14.0)

 Stroop T

19.0 (14.0–28.0)

< 36.91

10 (17.5)

 Trail making test B - T

149.0 (112.0–220.0)

111.29″-248.89″

10 (17.5)

 Trail making test B - E

1.0 (0–2.0)

−0.21-2.39

6 (10.5)

 Drawings

5.0 (3.0–6.0)

3.85–6.15

16 (28.1)

 Wais Digit span

33.0 (23.0–45.0)

> 6.00

14 (24.6)

LANGUAGE

  

5 (8.8)*

 Verbal fluency test

33.0 (27.0–41.0)

> 17.35

5 (8.8)

SPEED OF PSYCHOMOTOR PROCESSING

  

18 (31.6)*

 Pegboard dom

72.0 (62.0–82.0)

55.94–74.32

18 (31.6)

 Pegboard non dom

75.0 (68.0–85.0)

59.68–80.30

10 (17.5)

DEPRESSION

  

12 (21.1)*

 Zung depression score

38.0 (31.0–46.0)

< 50.00

12 (21.1)

DAILY LIFE ACTIVITY

 IADL

8.0 (8.0–8.0)

< 7.00

  1. *Patients with at least one pathologic test in the relative domain. IQR Interquartile Range